Clinical Trial Update: A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL) [NA]

View source ↗

Summary

A completed clinical trial evaluating safety and effectiveness of 0.50 diopter astigmatism correction with the RxSight Light Adjustable Lens in aphakia and cata…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphakia
• Cataract

Drugs mentioned

• Light Adjustable Lens (LAL) (Light Adjustable Lens)

Snippet

Sponsor: RxSight, Inc. | Conditions: Aphakia, Cataract | NA | Status: COMPLETED | Results posted: 2021-06-11